ABSCI CORP (ABSI)

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in public equity (PIPE) by AMD, underscoring the ris

These stocks are moving in today's pre-market session

Get insights into the top gainers and losers of Wednesday's pre-market session.

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

$20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm Software

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

$20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct...

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Collaboration leverages Absci’s leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health applications

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Collaboration leverages Absci’s leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health...

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

VANCOUVER, Wash. and NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company,...

Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

Drug candidate selected for ABS-201, a novel, potentially category-defining anti-PRLR antibody in development for androgenic alopecia Leading AI...

Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

/PRNewswire/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the...

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration...

Absci to Host R&D Day on December 12, 2024

Absci to Host R&D Day on December 12, 2024

VANCOUVER, Wash. and NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company,...

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

Collaboration brings together Absci’s Generative AI drug creation platform with Twist’s DNA synthesis platform to accelerate the design of a novel therapeutic antibody

Absci to Participate in Upcoming Investor Conferences

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

VANCOUVER, Wash. and NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company,...

ABSI Crosses Above Key Moving Average Level

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor keeps adding to some of her favorite falling stocks.

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor keeps adding to some of her favorite falling stocks.

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company,...

ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Absci (NASDAQ:ABSI) just reported results for the second quarter of 2024.Absci ...

ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q2 2024

ABSI stock results show that Absci missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Released results from non-human primate studies for ABS-101, demonstrating 2-3x extended half-life as compared to antibodies in clinical development ...